Emerging opportunities in the viral vector manufacturing market include personalized medicine growth, expanded clinical trials, and regional manufacturing partnerships. Advances in bioprocessing and ...
Therapeutics Co. Ltd. ( ($HK:2126) ) has issued an announcement. JW Therapeutics announced that the National Medical Products ...
OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s ...
Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback